title: [The effect of osteochin on the dynamics of the course of the myodystrophic process].
abstract: Osteochin (Quinoin, Hungary) efficacy was studied in the treatment of 20 patients with Duchenne's progressive myodystrophy. The drug was administered in a dose of 200 mg a day for a month. A favorable effect of such therapy was observed in all the patients. Osteochin was found to have a correcting effect on Ca-regulating hormone function and to promote stabilization of the myodystrophic process.
authors.forename: P A
authors.initials: PA
authors.lastname: Temin
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Nikanorova
authors.forename: L N
authors.initials: LN
authors.lastname: Kamennykh
authors.forename: A M
authors.initials: AM
authors.lastname: Mizitova
authors.forename: V A
authors.initials: VA
authors.lastname: Aleksandrovskiĭ
mesh_terms: D015650:24,25-Dihydroxyvitamin D 3 / Q000097:blood; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D008124:Locomotion / Q000187:drug effects; D009136:Muscular Dystrophies / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D010281:Parathyroid Hormone / Q000097:blood; D013607:Tablets
chemical_list: D002121:Calcium Channel Blockers; D010281:Parathyroid Hormone; D013607:Tablets; D015650:24,25-Dihydroxyvitamin D 3
vernacular_title: Izuchenie vliianiia osteokhina na dinamiku techeniia miodistroficheskogo protsessa.